Quantcast
Last updated on April 16, 2014 at 5:49 EDT

Latest Applied genetics Stories

2011-02-08 14:06:00

AMSTERDAM, February 8, 2011 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today that it will release its financial results for the year ended December 31, 2010 on Wednesday, February 16, 2011 at 07:00 AM Central European Time (CET). To discuss these results, AMT's management will conduct a conference call at 3:30 PM CET, which will also be webcast. To participate in the conference call, please call...

2011-02-07 18:21:16

Defects in the genome are the cause of many diseases. Gene therapy "“ direct replacement of mutant genes by intact DNA copies "“ offers a means of correcting such defects. Now a research team based at the Medical Center of the University of Munich, and led by Privatdozent Dr. Carsten Rudolph, has taken a new approach that avoids DNA delivery. The team shows for the first time that chemical modification of mRNAs (the metabolically active molecules derived from genomic DNA that...

2011-01-10 07:00:00

CARLSBAD, Calif., Jan. 10, 2011 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced today that it will hold a conference call focused on Genzyme's recent regulatory discussions with the FDA about the mipomersen NDA filing. Genzyme plans to communicate at its JP Morgan presentation Tuesday that: It had a productive meeting with the FDA. Based on FDA feedback, it believes the mipomersen package for HoFH is sufficient for filing. Due to the size of the severe HeFH...

2011-01-10 00:00:00

AMSTERDAM, January 10, 2011 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in human gene therapy, announced today that it has entered into an agreement with Institut Pasteur, Paris, France, and a group of French research institutes (together the "Consortium") to support clinical development of a novel gene therapy to treat Sanfilippo B. This rare genetic disease affecting new-born children leads to progressive neuronal degeneration and death. There is...

2011-01-05 22:55:33

Described in Human Gene Therapy A new, simplified method for producing large amounts of viral vector cassettes capable of shuttling genes into host cells will help advance the promising field of gene therapy as applications move into large animal studies and human clinical trials. The novel adeno-associated virus (AAV) production method is described in an article published Instant Online ahead of publication in Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc....

2011-01-04 00:00:39

Why wonder when you can get results now at Any Lab Test Now® Atlanta, GA (Vocus/PRWEB) January 03, 2011 With out of wedlock birth rates in the US on the rise Any Lab Test Now® offers legally-admissible paternity tests that can be used in a court of law. The test results can also be used as evidence needed to complete a birth certificate or Voluntary Acknowledgement of Paternity, or add a child to a father's medical or social security benefits program. "In 2008, a record 41% of...

099af4eced433fed4b50ba623cc15f081
2010-12-22 09:20:00

You know when you're watching a pirated film downloaded from the Internet "” there's no mistaking the fuzzy footage, or the guy in the front row getting up for popcorn. Despite the poor quality, pirated video is a serious problem around the world. Criminal copyright infringement occurs on a massive scale over the Internet, costing the film industry "” and the U.S. economy "” billions of dollars annually. Now Dr. Alex Bronstein of Tel Aviv University's Department of...

2010-12-07 01:52:45

Vector-gene combination developed at St. Jude Children's Research Hospital and UCL is central to latest clinical trial of gene therapy as a possible tool to provide long-term relief from disabling bleeds Investigators report no evidence of toxicity in the four hemophilia B patients enrolled to date in a gene therapy trial using a vector under development at St. Jude Children's Research Hospital and UCL (University College London) to correct the inherited bleeding disorder. This trial was...

2010-12-02 00:00:00

AMSTERDAM, December 2, 2010 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (AMT) Holding N.V. (Euronext: AMT), a leader in the development of gene-based therapies, today announced that it has amended and restated its licensing agreement with Amgen (Nasdaq: AMGN) for gene therapy applications incorporating the GDNF (glial cell derived neurotrophic factor) gene, to which Amgen holds rights. Financial terms were not disclosed. The GDNF gene contains the information to...

2010-11-07 10:47:03

Scientists present latest research findings on the public's understanding, use, and attitudes toward personalized genetic testing at ASHG 60th Annual Meeting Thousands of the world's top scientists and clinicians in the human genetics field will convene to present their latest research findings at the American Society of Human Genetics 60th Annual Meeting, which will be held November 2-6, 2010, in Washington, D.C. A number of scientific presentations at this year's meeting will provide...